exit_to_appLogin
FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
Signup
Frontpage iOS AppFrontpage Android App
forum

HIKAL Share Price Discussion

Hikal Ltd.
Sector: Pharmaceuticals and health care
... Read more
HIKAL Long Term Analysts Rating
  • ★
    ★
  • ★
    ★
  • ★
    ★
  • ★
    ★
  • ★
    ★
5/5 (5 Ratings)
HIKAL Share Price *
131.4 +2.7 (2.1%)
* (quote may be delayed)

Find answers to all your questions on live HIKAL message board: Is HIKAL buy or sell? Should I buy HIKAL shares? Why are HIKAL shares falling? Should I invest in HIKAL stock?


You can also check HIKAL share price target recommended by brokerages.

HIKAL Discussion Forum

TTA
 • 
HIKAL
•
Yesterday 8:33 PM
@TTA • Reputation: 5,748
Hikal: Expecting strong growth.buy INR 128. Target price INR 214.5
Growth to pick up in Going ahead: In both segments, H1 has impacted due to multiple factors like NGT order, destocking by clients, heavy flooding, annual maintenance shutdown. We believe this has impacted company ...
Read more...
Like
reply
Reply
DataBot
 • 
HIKAL
•
Oct 31 9:00 PM
@databot • Reputation: 1,317
ICICIdirect.com Recommendation on HIKAL
Date: 30-Oct-19 Broker: ICICIdirect.com Price @ Call: 117.09 Target: 140 Recommendation: BUY
Like
reply
Reply
NewsBot
 • 
HIKAL
•
Aug 18 3:23 PM
@newsbot • Reputation: 1,933
These 9 midcap, smallcap stocks look attractive in a fragile market: Do you own any?
Market experts advise a prudent, stock-specific approach in such an uncertain market
Moneycontrol
Like
reply
Reply
NewsBot
 • 
HIKAL
•
Jul 25 3:33 PM
@newsbot • Reputation: 1,933
Like
reply
Reply
NewsBot
 • 
HIKAL
•
May 23 8:43 PM
@newsbot • Reputation: 1,933
Like
reply
Reply
S
SANDYKUMAR
 • 
HIKAL
•
May 10 6:11 PM
@SANDYKUMAR • Reputation: 618
MIDCAP SMALL CAP...


POSITIONAL....CASH

BUY HIKAL AT CMP
ADD 20% HERE
30-50% NEAR 171-72
N
HOLD ON TILL TGT 180-186++++
SL BELOW 168
Like
reply
Reply (1)
Latest replies
SANDYKUMAR @SANDYKUMAR
•
May 10 8:47 PM
HIKAL START MOVING UP
🤣🤣🤣🤣

Try TO BOOK NEAR 176+
OR HOLD WITH SL STILL TGT SAME AS GIVEN
NewsBot
 • 
HIKAL
•
Apr 17 9:23 PM
@newsbot • Reputation: 1,933
Like
reply
Reply
NewsBot
 • 
HIKAL
•
Apr 17 6:48 PM
@newsbot • Reputation: 1,933
Like
reply
Reply
NewsBot
 • 
HIKAL
•
Apr 12 4:33 PM
@newsbot • Reputation: 1,933
Like
reply
Reply
NewsBot
 • 
HIKAL
•
Oct 31 3:27 PM
@newsbot • Reputation: 1,933
Like
reply
Reply

  • HIKAL - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization2,186.88
    Enterprise Value2,755.14
    Price to Earnings21.93
    Price to Book Value2.89
    Return on Capital Employed0.12
    Return on Equity0.12
    Face Value2
    Dividend Yield0.01

  • HIKAL Share Price - Technicals

    keyboard_arrow_down
    HIKAL - 52 Week High₹187.7
    HIKAL - 52 Week Low₹100.3

  • HIKAL - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    30-Oct-19ICICIdirect.comBuy140
    2-Aug-19ICICIdirect.comBuy190
    13-May-19ICICIdirect.comBuy205
    18-Apr-19HDFC SecuritiesBuy218
    4-Mar-19ICICIdirect.comBuy200
    HIKAL Brokerage Price Target

  • HIKAL Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Jan 22130134.5128.25131.6
    Jan 21128.85130.4127.2128.7
    Jan 20131.5133.5129.2129.7
    Jan 17129.1132.4128128.4
    Jan 16131.75133.5128.1129.05

  • HIKAL Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹122.14
    30 Day Moving Average₹117.83
    50 Day Moving Average₹114.8
    100 Day Moving Average₹127.32
    200 Day Moving Average₹146.4

  • HIKAL - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue1,2961,013.940.28
    Operating Profit242196.470.23
    Profit Before Tax11182.940.34
    Net Income7766.790.15

  • HIKAL - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds7576680.13
    Total Liabilities9309080.02
    Total Assets1,6861,5780.07

  • HIKAL - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity138163.49-0.16
    Cash from Investing Activity-110-102.590.07
    Cash from Financing Activity-24-63.27-0.62
    Net Cash Flow3-2.37-2.27

  • HIKAL - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.050.05
    Return on Equity0.120.12
    Return on Capital Employed0.120.13

  • HIKAL - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.49
    3 Year CAGR Growth in Operating Profit0.36
    3 Year CAGR Growth in EBIDTA0.33
    3 Year CAGR Growth in Net Income0.9
    3 Yr CAGR Growth - Diluted EPS0.9

  • HIKAL - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue0.96
    5 Year CAGR Growth in Operating Profit0.78
    5 Year CAGR Growth in EBIDTA0.72
    5 Year CAGR Growth in Net Income2.02
    3 Yr CAGR Growth - Diluted EPS-0.4

  • HIKAL - Recent News

    keyboard_arrow_down
    NewsBot
    Aug 18 3:23 PM
    These 9 midcap, smallcap stocks look attractive in a fragile market: Do you own any?
    Moneycontrol
    NewsBot
    Jul 25 3:33 PM
    NewsBot
    May 23 8:43 PM
    NewsBot
    Apr 17 9:23 PM
    NewsBot
    Apr 17 6:48 PM
    NewsBot
    Apr 12 4:33 PM
    NewsBot
    Oct 31 3:27 PM

  • HIKAL - Related Communities

    keyboard_arrow_down
    Sun Pharmaceutical Industries Ltd. S...
    Aurobindo Pharma Ltd. Sector: Pharma...
    Biocon Ltd. Sector: Pharmaceuticals ...
    Cipla Ltd. Sector: Pharmaceuticals a...
    Lupin Ltd. Sector: Pharmaceuticals an...
    Dr. Reddy's Laboratories Ltd. Sector...
    Piramal Enterprises Ltd. Sector: Phar...
    Glenmark Pharmaceuticals Ltd. Sector...
    Divi's Laboratories Ltd. Sector: Pha...
    Strides Pharma Science Ltd. Sector: P...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.
FrontPage Apps
Frontpage iOS AppFrontpage Android App
HelpAboutPrivacyTermsDisclaimersRefunds